Hormonal Contraceptives May Raise Risk of a Cardiovascular Event

What counts as a “cardiovascular event” in birth control conversations?

When researchers and clinicians talk about cardiovascular events related to hormonal contraceptives, they’re usually talking about:

• Venous thromboembolism (VTE): blood clots in veinsmost commonly deep vein thrombosis (DVT) in the leg or pulmonary embolism (PE) in the lungs.
• Ischemic stroke: a clot blocks blood flow to the brain.
• Myocardial infarction (heart attack): a blockage reduces blood flow to the heart muscle.

The headline risk for most people is VTE. Stroke and heart attack are much rarer in younger adults, but the risk can rise sharply
when certain risk factors stack up (think: smoking + high blood pressure + estrogen).

Why estrogen is usually the “main character” in clot risk

Hormonal contraceptives come in many forms, but the big risk split is this:
methods that contain estrogen vs. methods that do not.

Estrogen (typically ethinyl estradiol in many combined methods) can shift the body’s clotting balance in a pro-thrombotic direction.
One simple way to picture it: your blood has a constant job interview between “clot when needed” and “don’t clot randomly.”
Estrogen can bias the panel toward “more likely to clot,” especially early after starting, restarting, or when other risk factors are present.

Progestin-only methods can still have effects on cardiovascular risk depending on the formulation and the person,
but in general, estrogen-containing methods are the ones most clearly linked to higher clot risk.

Which hormonal contraceptives are linked to higher cardiovascular risk?

1) Combined hormonal contraception (CHC): pill, patch, and ring

CHC means estrogen + progestin. It includes many combined oral contraceptives (COCs), the transdermal patch, and the vaginal ring.
This category has the clearest association with increased VTE risk, and in certain situations, stroke or heart attack risk.

Combined pills (COCs): Often the most studied. Modern low-dose formulations are generally safer than older high-estrogen pills.
But “safer than the 1970s” is a low barlike bragging your phone battery is better than a potato.
The key point: relative risk can increase, but absolute risk usually remains low for healthy, nonsmoking users.

The patch: The patch is convenient (no daily pill), but it can produce different estrogen exposure than pills.
Some labels and clinical discussions note that certain patch products can lead to higher overall estrogen exposure,
which may increase estrogen-related adverse events like VTE in susceptible people.
Some patch labels also highlight higher VTE risk in people above specific BMI thresholds.

The ring: Like the pill and patch, the ring is an estrogen-containing CHC and carries similar categories of risk.
The ring can be a great option for people who want something monthly instead of daily,
but it’s still in the “contains estrogen” bucketmeaning the same high-risk groups usually shouldn’t use it.

2) Progestin-only options: generally lower cardiovascular risk

If estrogen is the main character in clot risk, progestin-only methods are the supporting cast that usually causes less drama.
Options include:

• Progestin-only pills (POPs) (often called the “mini-pill”)
• The implant
• The injection (commonly depot medroxyprogesterone acetate)
• Hormonal IUDs (levonorgestrel-releasing IUDs)

In many guidelines and patient resources, estrogen-free options are often recommended for people who have higher clot risk
or who should avoid estrogen (for example: certain smokers over age 35, people with migraine with aura,
or those with a history of blood clots).

3) Non-hormonal methods: no hormone-related clot risk

It’s worth saying out loud: no hormones means no hormone-related clot risk.
Options include copper IUD, condoms, diaphragms, spermicide, fertility awareness-based methods, etc.
Each has different effectiveness and lifestyle considerations, but from a cardiovascular standpoint, they’re the calmest option.

The “risk amplifier” list: who should pay extra attention?

Here’s where things get real: your baseline risk matters more than the brand name on the blister pack.
Major factors that can raise cardiovascular risk with estrogen-containing contraception include:

• Smoking (especially age 35+ and heavier smoking)
• High blood pressure (especially uncontrolled)
• Migraine with aura
• History of VTE, stroke, or heart disease
• Known clotting disorders (thrombophilias)
• Obesity (risk can increase as BMI increases; some patch products have specific BMI warnings/contraindications)
• Diabetes with vascular disease or multiple cardiovascular risk factors
• Postpartum period (especially in the early weeks after childbirth)
• Major surgery / prolonged immobility

In U.S. clinical guidance used by many clinicians, combined hormonal contraceptives are generally not recommended
or are contraindicated for certain groups because the health risks outweigh the benefits.
For example, smoking at age 35 or older becomes a major red flag for estrogen-containing methods,
and migraine with aura is commonly treated as a “no estrogen” situation.

Absolute risk: numbers that keep the conversation grounded

Risk discussions go off the rails when we talk only in “relative risk” (like “two times higher!”)
without stating what it’s two times higher than.
Two times higher than tiny can still be tiny.

Typical ranges you’ll see in reputable medical resources

• Baseline VTE risk (no hormonal contraception): often cited around a few cases per 10,000 people per year.
• Estrogen-containing contraception (CHC): commonly estimated in the single digits to low double digits per 10,000 woman-years.
• Pregnancy and the postpartum period: higher than CHC, with postpartum typically the highest-risk window.

Translation: for most people, the risk is uncommonbut the consequences can be serious, so clinicians take it seriously.
And it’s exactly why “Which method?” and “Which person?” matters more than a one-size-fits-all headline.

How clinicians decide: the short version of medical eligibility categories

In U.S. practice, many clinicians use a structured, evidence-based guide to match contraceptive methods to medical conditions.
The idea isn’t to restrict choiceit’s to reduce preventable harm.

Examples of how this plays out in real life

• Smoker, age 36: Estrogen-containing methods are often avoided, especially with heavier smoking.
  Progestin-only or non-hormonal options are commonly discussed first.
• Migraine with aura: Estrogen is typically avoided because the baseline stroke risk is higher in migraine with aura,
  and adding estrogen may increase risk further.
• History of blood clots or stroke: Estrogen-containing contraception is usually contraindicated.
  Clinicians may recommend progestin-only or non-hormonal methods.
• Postpartum: In the first weeks after childbirth, clot risk is already elevated.
  Many resources recommend waiting a specific period before starting estrogen-containing contraception,
  and individual circumstances (breastfeeding, other risks) matter.

This is why “I want the pill” is only the start of the conversation.
The better question is: “Which method gives me the benefits I want with the lowest risk for my health profile?”

So… should you stop your hormonal contraception?

If you’re healthy, don’t smoke, and don’t have high-risk conditions, the answer is usually:
don’t panic, don’t abruptly stop, and don’t let TikTok practice medicine on you.
Stopping suddenly can lead to unintended pregnancyand pregnancy itself can carry a higher clot risk than many contraceptives.

If you do have risk factors (especially smoking over age 35, migraine with aura, uncontrolled hypertension,
or a personal history of clots), it’s worth having a prompt conversation with a clinician about switching
to a lower-risk option.

Warning signs: when to seek urgent care

Cardiovascular events are rare, but you should take symptoms seriously.
Seek medical care urgently if you have:

• Chest pain, chest pressure, or shortness of breath
• Sudden severe headache or a headache that’s different/worse than usual
• Sudden weakness, numbness, trouble speaking, or facial droop
• Leg pain/swelling (especially one-sided), warmth, or redness
• Vision changes or new neurologic symptoms (especially with migraine aura)

If you’re unsure, it’s better to be evaluated and told “all clear” than to ignore symptoms that need treatment.

Lower-risk options if estrogen isn’t a good fit

If you and your clinician decide estrogen isn’t ideal, you still have plenty of effective choices:

• Progestin-only pill (POP): estrogen-free and often used when estrogen is contraindicated.
• Implant: long-acting, low maintenance, and estrogen-free.
• Hormonal IUD: highly effective with mostly local hormone effects in the uterus.
• Copper IUD: hormone-free and long-acting.
• Barrier methods: no hormones, plus condoms help reduce STI risk.

The “best” option depends on your health profile, your bleeding preferences, your tolerance for side effects,
and how much you want to think about birth control on a daily basis (some people want “set it and forget it,”
others prefer easy stop-start control).

Common questions people ask (and the answers they deserve)

“Does every hormonal contraceptive raise cardiovascular risk?”

No. The clearest increases are linked to estrogen-containing methods (combined pill/patch/ring).
Progestin-only methods are generally considered lower risk for clot-related events in many people.

“Is the patch riskier than the pill?”

Some patch products can create different estrogen exposure than typical pills,
and product labeling may include specific warnings about VTE risk and contraindications based on BMI or smoking.
The short answer: it can depend on the product and your personal risk factors.

“If the risk is ‘small,’ why talk about it?”

Because rare doesn’t mean irrelevant. Blood clots, stroke, and heart attack can be severe.
The goal is not fearit’s smart matching: choosing a method that keeps your risk low while meeting your needs.

“If I’m worried, should I switch to a non-hormonal method?”

Not automatically. Many people can safely use hormonal contraception.
But if you have risk factors (or simply prefer no hormones), non-hormonal options can be excellent.
Your preferences count, too.

Experiences that come up again and again (real-world, not-one-size-fits-all)

To make this topic less abstract, here are common “experience patterns” clinicians hearcomposites of real conversations
that reflect how people think and feel about cardiovascular risk, convenience, side effects, and peace of mind.
This isn’t medical advice, and it’s not meant to diagnose anyone; it’s meant to show how the decision process often plays out.

Experience #1: “I love the convenience… but I’m 38 and I still smoke.”

A lot of people start with the combined pill (or patch/ring) because it’s familiar, widely used, and works well.
Then life happens: the daily habit sticks, but a few risk factors accumulateage creeps up, stress is high,
and quitting smoking is still “the plan” (the plan has been the plan for seven years).
In these conversations, clinicians often don’t shame anyone; they simply reframe the risk:
estrogen plus smoking after 35 is a combination that can meaningfully increase the chance of serious cardiovascular events.
People are often relieved to hear there are solid estrogen-free options (POP, implant, IUD) that can keep effectiveness high
while lowering clot-related risk.

Experience #2: “My migraines have auradoes that change everything?”

Many people don’t realize migraine type matters. Someone might say, “I get migraines,” and only later mention the aura
flashing lights, zigzags, temporary visual loss, or neurologic symptoms before the headache.
Once aura is on the table, clinicians often steer away from estrogen-containing methods because migraine with aura
is associated with increased ischemic stroke risk.
People sometimes feel frustrated (“But the pill helped my cycle headaches!”), so the conversation becomes a balancing act:
can a progestin-only method control symptoms enough while keeping the safety profile favorable?
For many, switching reduces anxiety because the plan aligns with their risk profile.

Experience #3: “Postpartum brain is real, and I just want something I can’t mess up.”

After childbirth, people often want reliable contraception without extra mental load.
But the postpartum period is also a time when clot risk is higher, so timing and method choice matter.
In practice, this can look like choosing a progestin-only method early on, or an IUD placed at an appropriate time,
then revisiting options later when the postpartum clot-risk window has passed.
The emotional experience here is often relief: choosing something safe and effective feels like getting one more thing
off an already overflowing mental checklist.

Experience #4: “I chose the patch for convenience, but my clinician talked a lot about BMI and clot risk.”

Some patch products include specific warnings about use above certain BMI thresholds, and people can feel singled out.
The best conversations acknowledge that weight discussions are sensitive, then keep it clinical:
certain products may carry higher VTE risk at higher BMI, and effectiveness can also change.
People often appreciate being offered alternatives that don’t require daily action:
implant, hormonal IUD, or copper IUDchoices that can feel empowering rather than limiting.

Experience #5: “I read one scary story and now I’m spiraling.”

This is incredibly common: someone sees a headline about stroke risk and suddenly every calf cramp feels like a medical emergency.
What helps is perspective plus personalization. Clinicians often explain absolute risk, screen for risk factors,
and review warning signs that deserve urgent evaluation.
Many people leave the conversation calmernot because the risk was dismissed, but because it was made understandable:
“Here’s your risk profile, here are safer options if you want them, and here’s what to watch for.”
The experience becomes less fear-driven and more choice-driven, which is exactly where healthcare decisions should live.

Conclusion

Yescertain hormonal contraceptives, especially estrogen-containing methods, can raise the risk of cardiovascular events like blood clots
and (more rarely) stroke or heart attack. But for many healthy, nonsmoking people, the absolute risk remains low.
The smartest takeaway isn’t “hormones are bad.” It’s: match the method to the person.

If you have major risk factorssmoking over 35, migraine with aura, uncontrolled high blood pressure, history of clots, or certain heart conditions
it’s worth discussing estrogen-free or non-hormonal options. And if you’re low risk, the conversation can be about reassurance,
warning signs, and picking the method you’ll actually use correctly (because “perfect use” is a myth for most humans).

Bottom line: you deserve contraception that supports your life and respects your healthwithout your cardiovascular system filing a formal complaint.